Altered expression of annexin II in human B-cell lymphoma cell lines  by Chiang, Yungping et al.
ELSEVIER Biochimica et Biophysica Acta 1313 (1996) 295-301 
BB 
Biochi~ic~a et Biophysica A~ta 
Altered expression of annexin II in human B-cell lymphoma cell lines 
Yungping Chiang, Randall G. Davis, Jamboor K. Vishwanatha * 
Department ofBiochemistry and Molecular Biology, University of Nebraska Medical Center, 600 South 42nd Street, Omaha, NE 68198-4525, USA 
Received 17 June 1996; accepted 17 June 1996 
Abstract 
Annexin II is a growth-regulated gene, whose expression is significantly increased in various human cancers. We examined annexin II 
expression i  11 human B-cell lymphoma cell lines and in normal B-cells. Wide variation was observed in the levels of annexin II in 
these cell lines. Annexin II everexpression was observed in 5 cell lines, while significantly reduced expression was observed in Raji, 
OMA-BL-1 and REH cell lines. Analysis of the annexin II gene, mRNA and protein in Raji and OMA-BL-1 cell lines indicated that 
annexin II gene was unaltered and that a low level of annexin II transcripts are produced in these cells. Down-regulation f annexin II 
expression was at the transcriptional level, and no reexpression of annexin II was observed after treatment of cells with demethylating 
agents. Thus methylation of 1the annexin II gene does not appear to be responsible for annexin II down-regulation. A slow migrating 
altered form of annexin II was detected in Raji and OMA-BL-1 cells, which was detected with the anti-chicken annexin II antiserum, but 
not with the anti-human anne~in II antiserum. The slow migrating annexin II species was found to be sensitive to dephosphorylation by 
calf intestinal alkaline phosphatase, resulting in reduction of the size of the protein on SDS-polyacrylamide g ls. The phosphorylated 
annexin II was also observed in nuclear extracts of human K562 and HeLa cells. Thus, Raji and OMA-BL-1 cells exclusively produce a
phosphorylated form of annexin II, and phosphorylated annexin II may be important for cell survival and proliferation. 
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I. Introduction 
Annexin II (also called calpactin I, lipocortin II, p 36) is 
a major cellular substrate for phosphorylation by various 
receptor- and non-receptor protein kinases (reviewed in 
[ 1 ]). The mechanism of transduction of mitogenic signals 
downstream of the initial phosphorylation event remains to 
be elucidated. Annexin II is present in cells as a monomer, 
and in association with calpactin I light chain (pl 1), a 
heterotetramer is formed which is found associated with 
the plasma membrane [2]. The monomer annexin II is seen 
in the nucleus [3,4], and extracellular occurrence of an- 
nexin II is also reported [15]. Based on its distribution in 
cells, various physiological functions have been assigned 
to various forms of annexin II, such as mitogenic signal 
transduction [6], DNA synthesis and cell proliferation [7], 
membrane fusion during exocytosis and endocytosis [8,9], 
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cation-dependent adhesion of tumor cells to endothelium 
[5], and as a receptor for tissue plasminogen activator 
[10,11]. 
We have previously reported an interaction of annexin 
II with DNA polymerase c~ in in vitro DNA replication 
[7]. Addition of antisense annexin II oligodeoxynucleotides 
to growing HeLa cells reduces ongoing DNA synthesis 
and retards cell cycle progression [12]. Immunodepletion 
of annexin II from Xenopus egg extracts results in inabil- 
ity of the extracts to support DNA synthesis, while addi- 
tion of purified annexin II to immunodepleted extracts 
restores the ability to synthesize DNA [13]. Annexin II 
levels are increased in a variety of cancers [14-18], further 
supporting a role of annexin II in cell proliferation. In this 
study, we examined annexin II expression in human B-cell 
lymphoma cell lines. We found a wide variation in annexin 
II expression in these cell lines. Two cell lines that have 
significantly reduced levels of annexin II were examined 
further. The data reported in this paper demonstrates that 
these two cell lines produce the phosphorylated form of 
annexin II exclusively. Thus, phosphorylated annexin II 
may be necessary for cell proliferation. 
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2. Materials and methods 
2.1. Cell culture, drug treatment and reagents 
The human B-cell lymphoma cell lines used in this 
study are: progenitor B-cell lines (Nalm-6, REH, HPB-Null, 
PBE-I), B-lymphoblast cell lines (WI-L2, TK-6, DW-10) 
and Burkitt's lymphoma cell lines (Raji, Ramos, OMA- 
BL-1, Namalwa). Human adenoids were used as a source 
of normal B-cells, and by cell sorting we determined that 
adenoids contained > 80% B-cells. HeLa and K562 cells 
were used as positive controls in all experiments. Cells 
were grown in a growth medium consisting of Eagle's 
minimum essential medium (Gibco-BRL, Grand Island, 
NY) supplemented with 10% heat-inactivated fetal bovine 
serum, L-glutamine (2 mM), penicillin (100 U/ml) and 
streptomycin (100 txg/ml). All cell lines were determined 
to be Mycoplasma-negative by a PCR-based Mycoplasma 
detection assay. 5-aza-2'-deoxycytidine (d oxyC, Sigma 
Chemical Co., St. Louis, MO) was freshly prepared in 
distilled water, and cells were treated as indicated in figure 
legends. Genomic DNA, total cellular RNA and protein 
were extracted from cells using previously published pro- 
cedures [16,17]. Dephosphorylation f extracts was per- 
formed by incubation of 20 txg of extract with 2 units of 
calf intestinal alkaline phosphatase (Gibco-BRL, Grand 
Island, NY) at 37°C for 30 min in 50 mM Tris-HC1, 0.1 
mM EDTA (pH 8.5). Dephosphorylated extracts were then 
subjected to SDS-PAGE and immunoblot analysis. 
2.2. Antibodies 
Polyclonal rabbit anti-human annexin II antisera (~774) 
was a gift from Dr. Blake Pepinsky (Biogen, Boston, MA). 
Polyclonal rabbit anti-chicken annexin II antiserum was 
generously provided by Dr. Tony Hunter, Salk Institute, La 
Jolla, CA. Polyclonal anti-human phosphogtycerate kinase 
antisera was prepared as described previously [4]. 
Total RNA was isolated from cells and 5 txg of total RNA 
was used in the ribonuclease protection assay. A 463-bp 
EcoRI/Pst I  fragment of annexin II cDNA (corresponding 
to nucleotides 9-471 from pGAF5 [15]) was cloned into 
pGEM4Z vector (Promega, Madison, WI) and was used to 
transcribe a radiolabeled probe. Ribonuclease protection 
assays were performed using the RPAII kit (Ambion, 
Austin, TX) as directed. Briefly, each reaction contained 5 
txg of RNA and 2 X 105 cpm of 32p-labeled probe. Con- 
trol reactions were performed simultaneously using 5 Ixg 
of yeast RNA. Hybridizations were carried out for 16 h at 
42°C. Ribonuclease digestions were then performed using 
a mixture of RNase A and T 1 for 1 h at 37°C. Reaction 
products were separated on a 6% polyacrylamide-urea g l. 
The dried gel was scanned on a Betascope 603 (Betagen, 
Waltham, MA) and radioactivity in each band was quanti- 
tated. Twenty Ixg of total RNA was used in Northern blot 
experiments. Annexin I! probe was prepared from the 
vector pGAF5 [15] by the random primer method of 
labeling to a specific activity greater than 1 × 108 cpm/~zg. 
Hybridization of the probe to the membrane was carried 
out at 42°C overnight. Quantitation of blots was done by 
scanning the blots on a Betascope 603 radioanalytical 
imager (Betagen) and by cutting out the respective area of 
the blot and determining radioactivity by liquid scintilla- 
tion counting. Expression of the message for glyceralde- 
hyde phosphate dehydrogenase (GAPDH) was used as a 
control in both Northern blots and RPA to normalize data 
for annexin II levels to account for variation in loading the 
gel. 
2.5. Southern blot analysis 
Southern blot analysis [19] of genomic DNA was per- 
formed using annexin II cDNA from pGAF5-1 (1.0 kb), 
radiolabeled as described under Northern blotting, as a 
probe. 
2.3. Gel electrophoresis and immunoblotting 3. Results 
Proteins were resolved on 4-15% polyacrylamide gels 
under denaturing conditions and electrotransferred onto 
Immobilon-P (Millipore Corp, Boston, MA) transfer mem- 
branes as described previously [7]. The membranes were 
subjected to immunoblotting as described previously [7]. 
The blots were exposed to a Kodak X-Omat AR film with 
a Cronex-plus intensifying screen at -80°C. For quantita- 
tion of the immunoreactive band, the blot was scanned on 
a Betascope 603 (Betagen, Waltham, MA) radioanalytical 
imager. 
2.4. Analysis of steady-state annexin H message levels 
Steady-state mRNA levels of annexin II was examined 
by ribonuclease protection assay and Northern blotting. 
3.1. Expression of annexin H in human B-cell lymphoma 
cell lines 
Annexin II protein levels in various B-cell lymphoma 
cells and other control cells were measured by immunoblot 
analyses. A typical autoradiogram is shown in Fig. 1. 
Extracts made from adenoid cells (containing > 80% B- 
cells) were used as control normal cells, and HeLa cell 
extracts were used as positive controls. The data from Fig. 
1 indicate a wide variation in annexin II expression i  the 
cell lines. Normal B-cells (lane 14) contain detectable 
levels of annexin II. B-lymphoblast cell lines TK-6 and 
WI-L2, and a Burkitt's lymphoma cell line Ramos ex- 
pressed annexin II at the level of normal B-cells. Other cell 
lines such as HPB-Null, DW-10, Nalm-6, Namalwa and 
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Fig. 1. Expression of annexin II in human B-cell ymphoma cell lines. Whole cell extracts were prepared from adenoids, HeLa and various B-cell 
lymphoma cell lines. Extracts equivalent to 20 t~g of protein were subjected to SDS-gel electrophoresis and immunoblotting. Proteins on the blot were 
reacted with a 1:2000 dilution of polyclonal et774 antiserum and 1:500 dilution of anti-human PGK antiserum (Rabbit 3.5), and the reactivity was assessed 
using 125I-labeled protein A. The blot was exposed to an X-ray film for 66 h at room temperature. Radioactivity in the immunoreactive bands was 
quantitated by scanning the blot c,n a Betascope 603 radioanalytical imager. Positions of the molecular weight markers, PGK and annexin II are indicated. 
PBE-1, had significant overexpression f annexin II. REH 
and two Burkitt's lymphorna cell lines, Raji and OMA-BL- 
1 showed no annexin II protein. Since all cultured cells 
analyzed thus far displayed annexin II expression, we 
analyzed annexin II expression in these cell lines by 
repeating immunoblots many times and by radioim- 
munoassay (data not shown), and confirmed lack of an- 
nexin II expression in these cell lines. However, the ex- 
pression of 3-phosphoglycerate kinase (Fig. 1), proliferat- 
ing cell nuclear antigen and the 70 and 90 kDa subunits of 
Ku autoantigen, were unaffected in these cell lines, indicat- 
ing a specific lack of expression of annexin II. 
3.2. Lack of annexin H in Raji and OMA-BL-1 cell lines is 
transcriptionally regulated 
We further examined annexin II expression i  Raji and 
OMA-BL-1 cells by using immunoblot, Northern blot, 
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Fig. 2. Analysis of annexin II protein, RNA and gene in Raji and OMA-BL-1 cell lines. Panel A shows a Western blot analysis of annexin lI protein levels 
in different preparations of Nalm-6, OMA-BL-1 and Raji cell extracts. Western blot analysis was done as described in Fig. 1. Panel B shows Northern blot 
analysis of annexin II mRNA expression in the control 293 and HeLa cells, annexin II-positive Nalm-6 and Ramos cell lines and annexin II negative 
OMA-BL-1 and Raji cell lines. Panel C shows the results of ribonuclease protection analysis. Positions of the annexin II (470 bp) and GAPDH (395 bp) 
probes and the protected annexin II (463 bp) and GAPDH (316 bp) fragments are indicated. Panel D shows Southern blot analysis of HeLa, Raji and 
OMA-BL-1 cells. Genomic DNA was digested with BamHI (B) and EcoRI (E) as indicated and Southern blot analysis was performed as described in 
Section 2. Positions of the molecular weight markers are indicated. 
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Fig. 3. Methylase inhibitor 5-aza-2'-deoxycytidine oes not cause reexpression f annexin II in Raji cells. Raji cells were cultured in the absence (C, lanes 
2,5,8) or presence of 0.75 /~M (lanes 3,6,9) and 7.5 p,M (lanes 4,7,10) of 5-aza-2'-deoxycytidine for 1-5 days as indicated. Protein extracts made from 
cells were subjected toWestern blot analysis as in Fig. 1, with the exception of using anti-chicken a nexin II polyclonal ntiserum (1:1000 dilution) as the 
primary antibody. The blot was exposed to X-ray film for 24 h at - 80°C. 
ribonuclease protection and Southern blot analyses (Fig. 
2). Repeated immunoblot analyses indicated lack of an- 
nexin II protein (panel A). Northern analysis of total 
cellular mRNA indicated specific lack of expression or 
down-regulation of annexin II in Raji and OMA-BL-1 
cells (panel B). When Northern blot analysis was repeated 
many times, in some blots a faint hybridization was visible 
in Raji and OMA-BL-1 cells. Therefore, we used a more 
sensitive ribonuclease protection assay to measure annexin 
II mRNA levels (panel C). In repeated ribonuclease protec- 
tion analyses, we found that Raji and OMA-BL-1 cells 
have greatly reduced annexin II mRNA. Compared to 
another human Burkitt's lymphoma cell line, Ramos, the 
Raji and OMA-BL- I  cells had a 40- to 50-fold reduction 
in annexin II mRNA levels (normalized to levels of 
GAPDH). There was no alteration in the annexin II ge- 
nomic DNA as seen by no change in the hybridization 
pattern after cleavage by restriction enzymes (panel D). 
Therefore, we conclude that the down-regulation of an- 
nexin II expression in Raji and OMA-BL-1 cells is at the 
transcriptional level. 
3.3. Down-regulation of annexin II expression in Raji cells 
is not due to gene methylation 
Human annexin II gene has been isolated and an exami- 
nation of upstream sequences reveal a highly GC rich 
region (72% GC), with a high frequency of CpG dinucleo- 
tide [20]. Methylation of the CpG dinucleotide has been 
shown to directly inhibit transcription or stabilize struc- 
tural changes in chromatin that prevent transcription 
[21,22]. We therefore used the nucleotide analogue, de- 
oxyC, to inhibit DNA methylation in Raji cells and mea- 
sure reexpression of annexin II mRNA and protein. Expo- 
sure of Raji cells to either low (0.75 IxM) or high (7.5 
~M) deoxyC did not result in reexpression of annexin II 
mRNA (data not shown). When immunoblot analysis was 
performed using the polyclonal ~774 antisera, we did not 
observe an immunoreactive protein band. However, when 
the polyclonal anti-chicken annexin II antisera was used, 
we observed a slower migrating immunoreactive protein 
band (Fig. 3). The slow migrating protein is a modified 
form of annexin II, since the anti-chicken annexin II 
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Fig. 4. Raft and OMA-BL-I cells express an altered form of annexin II. Whole cell extracts (20 ~g protein) from Raji, OMA-BL-I and Nalm-6 cells were 
subjected to SDS-PAGE and Western blot analysis as described in Fig. I. In panel A, the blot was developed with polyclonal anti-chicken annexin II
antisera (l:1000 dilution), and in panel B, ct774 antisera (1:2500 dilution) was used. In both panels, anti-PGK was used at I:1000 dilution. The blots were 
exposed to X-ray film at -80°C for 48 h. 
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Fig. 5. Phosphorylated annexin II is expressed in Raji and OMA-BL-I cells. Whole cell extracts from Raji and OMA-BL-1 cells were left untreated (lanes 
2 and 4) or treated with calf intestinal alkaline phosphatase (lanes 3 and 5). SDS-PAGE and immunoblot analysis of untreated and dephosphorylated 
extracts were performed as described in Fig. 1 with anti-chicken annexin II antiserum (panel A) and cx774 antiserum (panel B), along with anti-PGK 
antiserum (in both panels). HeLa cell extracts were included to indicate positions of annexin II and PGK migration. 
antiserum does not cross-react with other annexins or other 
cellular proteins in crude cell homogenates from several 
cell lines examined by us thus far [4,7,12,16]. 
3.4. Expression of phosphorylated annexin H is seen in 
Raft and OMA-BL-1 cells 
We further investigated the nature of the slower migrat- 
ing annexin II protein in Raji and OMA-BL-1 cells. Fig. 4 
illustrates results of immunoblot analyses of Nalm-6, Raji 
and OMA-BL-I cell extracts with e¢774 (panel A) or 
anti-chicken annexin II (panel B) antisera. Annexin II from 
Nalm-6 cells is immunoreactive with both antisera. How- 
ever, the slower migrating annexin II protein seen in Raji 
and OMA-BL-I cells is immunoreactive only with the 
anti-chicken antisera. Annexin II is a major cellular sub- 
strate for protein-tyrosine kinases and the physiological 
role of phosphorylated annexin II is unknown. We investi- 
gated the possibility that tile slower migrating annexin II is 
the phosphorylated form. Raji and OMA-BL- 1 cell extracts 
were dephosphorylated with calf intestinal alkaline phos- 
phatase, and immunoblot analysis was conducted on un- 
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Fig. 6. Phosphorylated annexin ~[I is present in nuclear extracts of K562 
cells. Cytosolic (lanes 3 and 4) and nuclear extracts (lanes 1 and 2) from 
K562 cells were prepared and subjected to treatment with alkaline 
phosphatase (Lanes 2 and 4). SDS-PAGE and immunoblot analysis with 
anti-chicken annexin II and anti--PGK antisera was performed. The posi- 
tions of the PGK, annexin II an,:l phosphorylated annexin II proteins are 
indicated. 
treated and dephosphorylated xtracts (Fig. 5). The data 
show a change in the mobility of the slower migrating 
annexin II protein upon dephosphorylation in both Raji 
and OMA-BL-1 extracts, and the dephosphorylated an- 
nexin II migrates to the same position as annexin II from 
Nalm-6 and HeLa cells. Thus, Raji and OMA-BL-1 cells 
produce phosphorylated annexin II exclusively, and at a 
significantly reduced amount compared to other cell lines. 
The dephosphorylated form of annexin II fails to be recog- 
nized by the ot774 antiserum. We further investigated if
the phosphorylated annexin II is associated with nuclei in 
other cell lines also. Previously, we have identified a 
slower migrating annexin II species in HeLa nuclear ex- 
tracts [4]. We prepared nuclear and cytosolic extracts from 
a human erythroleukemia cell line K562, and subjected 
these extracts to dephosphorylation with calf intestinal 
alkaline phosphatase. The data is shown in Fig. 6, Fig. and 
Fig. , and indicates the presence of a slower migrating, 
phosphatase-sensitive annexin II form in the nucleus that is 
not observed in the cytosolic extracts. Thus, phosphory- 
lated annexin II is associated with nuclei in a variety of 
cells examined. 
4. Discussion 
The physiological role of annexin II remains to be 
understood. Annexin II is implicated in having a role in a 
variety of cellular functions. The discovery of annexin II 
as a major substrate of protein-tyrosine kinases (reviewed 
in [1]) led to the proposal that annexin II is involved in 
mitogenic signal transduction. The calcium-dependent 
phospholipid binding activity along with the plasma mem- 
brane association of annexin II heterotetramer may be 
important for the membrane fusion activity of annexin II. 
Recent studies on the extracellular annexin II implicate 
annexin II in a receptor-like function that binds various 
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molecules uch as the tissue plasminogen activator [ 10,11], 
cytomegalovirus [23], an alternately spliced form of 
tenascin-C [24], and as a divalent cation-dependent adhe- 
sion molecule [5]. 
A role for annexin II in cell proliferation and DNA 
replication is indicated from a number of observations 
made in the past few years. Annexin II is a growth-regu- 
lated gene [25,26] and its expression is cell cycle regulated 
in mammalian cells [27]. In a complex with phosphoglyc- 
erate kinase, called the primer recognition protein com- 
plex, annexin II stimulates DNA polymerase c~ activity [7]. 
Exposure of HeLa cells to antisense annexin II oligo- 
nucleotides reduces the ongoing DNA synthesis [12], and 
immunodepletion of annexin II results in inability of 
Xenopus egg extracts to replicate exogenous DNA [13]. 
Overexpression of annexin II is seen in a number of cancer 
cells and tissues [14-18], and annexin II is present in all 
cultured cells. The exact mechanism of annexin II action in 
DNA synthesis and cell proliferation remains to be deter- 
mined. 
We examined 11 human B-cell lymphoma cell lines for 
annexin II expression, to investigate whether annexin II 
overexpression seen in other human cancers is also ob- 
served in B-cell lymphomas. We observed a wide variation 
in annexin II expression in these cell lines. While 3 cell 
lines had unaltered expression when compared to normal 
B-cells, five cell lines had significant overexpression. Most 
interestingly, 3 cell lines had significantly reduced or no 
expression of annexin II. Upon further investigation, we 
determined that the reduced annexin II expression in these 
cell lines was regulated at the transcriptional level. Using a 
sensitive ribonuclease protection assay, we observed a low 
level of annexin II transcripts in these cell lines. The 
transcriptional regulation of annexin II in B-cell lymphoma 
cell lines is consistent with previous observations of an- 
nexin II regulation seen in virus-transformed rat cell lines 
[28], human leukemias [29], and human hepatocarcinoma 
cells [30]. This transcriptional regulation is not due to 
methylation of the annexin II gene, since we did not 
observe reexpression of annexin II upon treatment of cells 
with demethylating agents. 
When immunoblot analyses were conducted with the 
anti-human recombinant annexin II serum (a774), we did 
not observe any annexin II protein in Raji and OMA-BL-1 
cells. However, when we used the anti-chicken annexin II 
antiserum, we observed a slower migrating immunoreac- 
five protein. The anti-chicken annexin II antiserum is 
monospecific for annexin II, and in whole cell extracts of 
many human and rodent cell lines, we do not see cross-re- 
activity of this antiserum with any other cellular protein 
[4,7,12,16]. Thus, Raji and OMA-BL-1 cells produce an 
altered form of annexin II. Annexin II is an excellent 
substrate for protein-tyrosine kinases, and we had previ- 
ously demonstrated the presence of an altered form of 
annexin II associated with nuclear matrix in HeLa cells [4]. 
We investigated whether the slower migrating annexin II 
in Raji and OMA-BL-I  cells is phosphorylated. Dephos- 
phorylation of cell extracts with calf intestinal alkaline 
phosphatase resulted in a change in the mobility of the 
altered form. The dephosphorylated protein migrated to the 
position of the major annexin II protein seen in other cells. 
Thus, Raji and OMA-BL-1 cells produce a phosphorylated 
form of annexin II exclusively. The expression of phos- 
phorylated annexin II is not limited to these two cell lines, 
as shown by the presence of the phosphorylated annexin II 
in nuclear extracts of K562 cells (Fig. 6) and in HeLa cells 
[4]. We have observed the slower migrating annexin II in 
all cell extracts, albeit at a considerably lower level than 
unphosphorylated annexin II. In the presence of a large 
excess of unphosphorylated annexin II, it is frequently 
difficult to observe the phosphorylated form. 
The data presented in this paper indicate that cultured 
cells can survive in the absence of a majority of annexin II, 
but the phosphorylated form of annexin II may be neces- 
sary for cell survival and proliferation. Our results provide 
the basis for future work on defining the physiological role 
of annexin II. The role of phosphorylated annexin II in 
DNA synthesis and cell proliferation needs to be estab- 
lished in future experiments. 
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